bioRxivBioengineeringPreprint
Tunable Magnetorheological Elastomer Substrates for Studying Mechano-Genetic Interactions in Hypertrophic Cardiomyopathy
Yasaman Kargar Gaz KoohiD, Yuwen SuniD, Ganesh MalayathiD, Leah Hayem, Bahareh BahmaniiD, Nongmaithem Debeni DeviiD, Huanzhu JiangiD, Feng Long, Sharon Cresci, Guy M. GeniniD, Nathaniel HuebschiD
Abstract
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. While sarcomeric genomic variants drive HCM, a role for mechanical stress in disease pathogenesis is increasingly appreciated. However, existing in vitro models of HCM rely on model systems (e.g., hydrogels) with static mechanical properties, precluding investigation of how dynamic mechanical loading interacts with genetic susceptibility during disease initiation. Here, we leveraged a dynamically tunable magnetorheological elastomer (MRE) platform to model progressive mechanical stiffening in order to study mechano-genetic interactions in human induced pluripotent stem cell (hiPSC) derived cardiomyocytes harboring an HCM-associated MYBPC3 frameshift (MYBPC3fs) loss-of-function variant. Dynamic stiffening selectively unmasked pathological structural remodeling in MYBPC3fs cardiomyocytes while producing only modest changes in isogenic controls, suggesting that MYBPC3fs confers heightened mechanosensitivity. In MYBPC3fs cardiomyocytes, mechanical stiffening drove hypertrophic remodeling, sarcomere disorganization, nuclear remodeling, dysregulated NFAT3 signaling, and aberrant cell-cycle activity. MRE stiffening also drove fibroblast-to-myofibroblast transition in primary cardiac fibroblasts, recapitulating early fibrotic remodeling. Together, these findings position dynamically tunable MRE substrates as a human-relevant platform for dissecting mechano-genetic disease mechanisms and evaluating therapies targeting mechanotransduction pathways in HCM.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mechanical Resistance to Micro-Heart Tissue Contractility unveils early Structural and Functional Pathology in iPSC Models of Hypertrophic Cardiomyopathy
J. GUO, H. Jiang, … N. Huebsch·bioRxiv·Oct 30, 2023
- Length-dependent hypercontractility decoupled from cellular adaptations is the initial phenotype in MYBPC3-haploinsufficient iPSC-derived engineered cardiac tissues
Tomi Tuomainen, Maike Mona Širinov, … Pasi Tavi·bioRxiv·May 15, 2026
- HCM-associated mutations in MYH6/7 drive pathologic expression of TGF-β1 in cardiomyocytes within weeks of developmental specification
Jeanne Hsieh, Megan A. L. Hall, … Brenda M. Ogle·bioRxiv·Aug 8, 2024
- MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids
Darshini A. Desai, Taejeong Song, … Sakthivel Sadayappan·CellsPeer-reviewed·Nov 19, 2024
- A contraction stress model of hypertrophic cardiomyopathy due to thick filament sarcomere mutations
R. Cohn, K. Thakar, … J. T. Hinson·bioRxiv·Sep 4, 2018
- Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy
J. Hsieh, K. Becklin, … B. M. Ogle·bioRxiv·Apr 5, 2022